Your browser doesn't support javascript.
loading
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.
Coca-Pelaz, Andrés; Shah, Jatin P; Hernandez-Prera, Juan C; Ghossein, Ronald A; Rodrigo, Juan P; Hartl, Dana M; Olsen, Kerry D; Shaha, Ashok R; Zafereo, Mark; Suarez, Carlos; Nixon, Iain J; Randolph, Gregory W; Mäkitie, Antti A; Kowalski, Luiz P; Vander Poorten, Vincent; Sanabria, Alvaro; Guntinas-Lichius, Orlando; Simo, Ricard; Zbären, Peter; Angelos, Peter; Khafif, Avi; Rinaldo, Alessandra; Ferlito, Alfio.
Afiliación
  • Coca-Pelaz A; Department of Otolaryngology, Hospital Universitario Central de Asturias-University of Oviedo, Oviedo, Asturias, Spain. acocapelaz@yahoo.es.
  • Shah JP; Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, CIBERONC, Oviedo, Asturias, Spain. acocapelaz@yahoo.es.
  • Hernandez-Prera JC; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ghossein RA; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
  • Rodrigo JP; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hartl DM; Department of Otolaryngology, Hospital Universitario Central de Asturias-University of Oviedo, Oviedo, Asturias, Spain.
  • Olsen KD; Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, CIBERONC, Oviedo, Asturias, Spain.
  • Shaha AR; Division of Surgical Oncology, Gustave Roussy Cancer Center and Paris-Sud University, Villejuif Cedex, Paris, France.
  • Zafereo M; Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN, USA.
  • Suarez C; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nixon IJ; Division of Surgery, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Randolph GW; Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, CIBERONC, Oviedo, Asturias, Spain.
  • Mäkitie AA; Department of Surgery and Otolaryngology, Head and Neck Surgery, Edinburgh University, Edinburgh, Scotland, UK.
  • Kowalski LP; Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Vander Poorten V; Department of Otorhinolaryngology, Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Sanabria A; Head and Neck Surgery and Otorhinolaryngology Department, A C Camargo Cancer Center, São Paulo, Brazil.
  • Guntinas-Lichius O; Section Head and Neck Oncology, Otorhinolaryngology-Head and Neck Surgery and Department of Oncology, University Hospitals Leuven, KU Leuven, Louvain, Belgium.
  • Simo R; Department of Surgery, School of Medicine, Universidad de Antioquia/Hospital Universitario San Vicente Fundación-CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello, Medellín, Colombia.
  • Zbären P; Department of Otorhinolaryngology, Institute of Phoniatry/Pedaudiology, Jena University Hospital, Jena, Germany.
  • Angelos P; Head and Neck Cancer Unit, Guy's and St Thomas' Hospital NHS Foundation Trust London, London, UK.
  • Khafif A; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital, Berne, Switzerland.
  • Rinaldo A; Department of Surgery, University of Chicago Medical Center, Chicago, IL, USA.
  • Ferlito A; Head and Neck Surgery and Oncology Unit, A.R.M. Center for Advanced Otolaryngology Head and Neck Surgery, Assuta Medical Center, Tel Aviv, Israel.
Adv Ther ; 37(7): 3112-3128, 2020 07.
Article en En | MEDLINE | ID: mdl-32488657
ABSTRACT

INTRODUCTION:

Aggressive variants of papillary thyroid cancer (PTC) have been described with increasing frequency. These variants include diffuse sclerosing variant, tall cell variant, columnar cell variant, solid variant, and hobnail variant.

METHODS:

We have performed a review of the more aggressive variants of PTC with respect to main characteristics, histological and molecular features, and the consequences that the knowledge of these variants should have in the treatment of the patients.

RESULTS:

At the present time, we do not know the prognostic value of these aggressive PTC variants. The extent of the surgical treatment and adjuvant therapy necessary should be decided on the basis of the extent of the tumor at presentation and the opinion of experienced clinicians.

CONCLUSION:

These aggressive variants should be known by clinicians, to avoid underdiagnosis, and treated according to the latest recommendations in the literature.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Neoplasias de la Tiroides / Carcinoma Papilar / Cáncer Papilar Tiroideo Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Neoplasias de la Tiroides / Carcinoma Papilar / Cáncer Papilar Tiroideo Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: España